Moreover, it was recently discovered that GRAMD1B is a downstream target of JAK-STAT signaling in gastric and breast cancer cell lines, and it is a key signaling molecule able to inhibit cell migration in breast cancer [51,52]. Here, GRAMD1B is linked to breast cancer.